Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
<div><p>The cancer testis antigen (CTA) lactate dehydrogenase C (LDHC) is a promising anticancer target with tumor‐specific expression and immunogenicity. Interrogation of breast cancer patient cohorts from The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer Internatio...
Saved in:
| Main Author: | Adviti Naik (673163) (author) |
|---|---|
| Other Authors: | Julie Decock (44558) (author) |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
by: A. Naik (7783220)
Published: (2023) -
Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
by: Remy Thomas (702843)
Published: (2020) -
Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer
by: Adviti Naik (673163)
Published: (2025) -
Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
by: Adviti Naik (673163)
Published: (2022) -
Modulation of SLFN11 induces changes in DNA Damage response in breast cancer
by: Christophe Michel Raynaud (17449906)
Published: (2023)